Related Experiment Video
Updated: Dec 19, 2025

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System
Published on: October 5, 2015
A Case of Vancomycin-Induced Immune Thrombocytopenia
Kira N MacDougall1, Sara Parylo2, Alisa Sokoloff3
1Internal Medicine, Staten Island University Hospital, Northwell Health, New York, USA.
Abstract:
Vancomycin-induced immune thrombocytopenia (ITP) is a rare, potentially life-threatening complication from an antibiotic frequently used in medical practice. We report a case of an 81-year-old male with recent removal of an infected right knee prosthesis and insertion of an articulating antibiotic spacer, presenting from rehabilitation for severe thrombocytopenia (1 X 103/µL). The patient's thrombocytopenia was initially falsely attributed to rifampin-induced ITP, a much more common cause of drug-induced thrombocytopenia. Only later, after a second precipitous drop in platelet count, vancomycin was correctly identified as the culprit. The patient's serum was tested for drug-dependent platelet antibodies with and without vancomycin. A positive reaction for IgG was detected by flow cytometry in the absence of vancomycin, which was potentiated in the presence of vancomycin. The result indicated the presence of vancomycin-dependent and nondrug-dependent platelet reactive antibodies and confirmed the diagnosis of vancomycin-induced ITP. In this case, the correct diagnosis was masked by the simultaneous administration of two drugs that cause drug-induced ITP and highlights the importance of early recognition of rare, vancomycin-induced ITP.
Insights
Vancomycin-induced immune thrombocytopenia (ITP) is a rare but serious condition. Early recognition is crucial, especially when other drugs may mask the diagnosis.
Area of Science:
- Internal Medicine
- Pharmacology
- Hematology
Background:
- Vancomycin is a critical antibiotic for serious infections.
- Immune thrombocytopenia (ITP) is a potential adverse drug reaction.
- Drug-induced ITP can be life-threatening.
Observation:
- An 81-year-old male developed severe thrombocytopenia post-knee prosthesis surgery.
- Initial diagnosis attributed thrombocytopenia to rifampin, not vancomycin.
- A second platelet drop led to identifying vancomycin as the cause.
Findings:
- Flow cytometry confirmed vancomycin-dependent and non-drug-dependent platelet reactive antibodies.
- The presence of IgG antibodies was detected.
- Vancomycin was confirmed as the causative agent for ITP.
Implications:
- Highlights the challenge of diagnosing vancomycin-induced ITP when other drugs are involved.
- Emphasizes the need for vigilant monitoring of platelet counts in patients on vancomycin.
- Underscores the importance of considering rare drug-induced ITP etiologies for prompt diagnosis and management.
Related Concept Videos
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Endocarditis IV: Nursing Management
Venous Thrombosis IV: Nursing Management
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Endocarditis III: Medical Management
Myocarditis IV: Nursing Management